摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-1,3-di(benzyloxycarbonyl)-1-(4-benzoyloxycarbonylamino-6-diazo-5-oxohexyl)guanidine | 89760-63-4

中文名称
——
中文别名
——
英文名称
(S)-1,3-di(benzyloxycarbonyl)-1-(4-benzoyloxycarbonylamino-6-diazo-5-oxohexyl)guanidine
英文别名
benzyl N-[(4S)-6-diazo-5-oxo-4-(phenylmethoxycarbonylamino)hexyl]-N-(N-phenylmethoxycarbonylcarbamimidoyl)carbamate
(S)-1,3-di(benzyloxycarbonyl)-1-(4-benzoyloxycarbonylamino-6-diazo-5-oxohexyl)guanidine化学式
CAS
89760-63-4
化学式
C31H32N6O7
mdl
——
分子量
600.631
InChiKey
IYVHOGAZWYZPGI-SANMLTNESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    44
  • 可旋转键数:
    17
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    152
  • 氢给体数:
    2
  • 氢受体数:
    8

SDS

SDS:062546c11df26e868c06df05a240b22c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Total Synthesis of the Anti Methicillin-Resistant Staphylococcus aureus Peptide Antibiotics TAN-1057A-D
    摘要:
    TAN-1057A-D, dipeptides isolated from bacteria Flexibacter sp. PK-74 and PK-176, are new antibiotics with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. We describe, in detail, the total synthesis of TAN-l057A-D by a convergent route featuring a new method to construct the cyclic amidinourea functional group.
    DOI:
    10.1021/ja972670j
  • 作为产物:
    参考文献:
    名称:
    TAN-1057 A/B 的全合成,一种来自 Flexibacter sp. 的新型二肽抗生素。PK-74
    摘要:
    TAN-1057 (1a, b) - 一种对耐甲氧西林金黄色葡萄球菌具有活性的新型天然二肽抗生素 - 从 Nα、Nδ、Nω-tri-ZL-精氨酸 20b 开始,通过相应的重氮酮 21b 合成。这在光解后重排为烯酮,其被 (±)-2,4,5,6-四氢-5-甲氨基-2-脲基嘧啶-4-一 (3) 捕获,得到完全保护的二肽 23 (30%) . 后者通过氢解脱保护得到最终化合物,为两种差向异构体的混合物 - TAN-1057A,B - 先前从 Flexibacter sp. 菌株中分离。PK-74。中间体3由3-氨基-2-(NZN-甲基氨基)丙酸甲酯盐酸盐(16)和2-甲基-2-硫代伪缩二脲氢碘化物(18)一步制备,产率为35%。
    DOI:
    10.1002/(sici)1099-0690(199805)1998:5<777::aid-ejoc777>3.0.co;2-w
点击查看最新优质反应信息

文献信息

  • Stabilized Analogs of Thymopentin. 2. 1,2- and 3,4-Ketomethylene Pseudopeptides
    作者:Joseph I. DeGraw、Ronald G. Almquist、Charles K. Hiebert、Amrit K. Judd、Linda Dousman、R. Lane Smith、William R. Waud、Itsuo Uchida
    DOI:10.1021/jm9508043
    日期:1997.7.1
    In this second paper in a series of three studies of stable analogs of thymopentin (Arg1-Lys2-Asp3-Val4-Tyr5), the synthesis of analogs stabilized at peptide bonds 1,2 and 3,4 via insertion of ketomethylene units is described. A tris(carbobenzyloxy)arginyl(k)norleucine pseudopeptide was synthesized and coupled to Asp-Val-Phe-resin units followed by HF cleavage to prepare Arg(k)Nle-Asp-Val-Phe analogs
    在第二篇论文中,对胸腺五肽(Arg1-Lys2-Asp3-Val4-Tyr5)的稳定类似物进行了三项研究,描述了通过插入酮亚甲基单元稳定在肽键1,2和3,4上的类似物的合成。合成了三(羰基苄氧基)精酰基(k)正亮酸假肽,并偶联至Asp-Val-Phe-树脂单元,然后进行HF裂解,以制备Arg(k)Nle-Asp-Val-Phe类似物。N-BOC Asp(k)Val和N-BOC Asp(k)Ala单元的制备,然后偶联至Phe-或Tyr-树脂单元,提供了与树脂结合的拟三肽底物,用于附着各种精酰二肽。从树脂上裂解得到胸腺五肽的3,4-酮亚甲基稳定的假肽类似物。与胸腺五肽本身相比,Arg-Lys-Asp(k)Val-Phe和Arg-Lys-Asp(k)Val-Tyr类似物与CEM细胞的结合更为牢固。
  • A new approach to the 2,5-diamino-5,6-dihydro-1H-pyrimidine-4-one derivatives: synthesis of TAN-1057A/B and analogs
    作者:Lijun Zhang、Lianhong Xu、Choung U. Kim
    DOI:10.1016/s0040-4039(03)01381-9
    日期:2003.7
    TAN-1057A/B has shown potent activity against MRSA. A new approach to the 2,5-diamino-5,6-dihydro-1H-pyrimidine-4-one derivatives has been developed. TAN-1057A/B and its analogs were efficiently synthesized using this new approach.
    TAN-1057A / B已显示出针对MRSA的有效活性。已经开发了一种新的2,5-二基-5,6-二氢-1 H-嘧啶-4-酮衍生物的方法。TAN-1057A / B及其类似物是使用这种新方法有效合成的。
  • A new and convergent synthesis for 2,5-diamino-tetrahydropyrimidones
    作者:Lianhong Xu、Lijun Zhang、Clifford M. Bryant、Choung U. Kim
    DOI:10.1016/s0040-4039(03)00226-0
    日期:2003.3
    AN1057A/B has shown potent activity against MRSA. A novel and concise route to the synthesis of its heterocycle core 2,5-diamino-5,6-dihydro-1H-pyrimidine-4-one is described. This methodology allows the synthesis of an array of analogs with different amine substitutions at the 2-position. (C) 2003 Elsevier Science Ltd. All rights reserved.
  • A facile construction of the 3,6-diamino-1,2,3,4-tetrahydropyridine-4-one scaffold: synthesis of N-3 to carbon replacement analog of TAN-1057A/B
    作者:Lijun Zhang、Choung U. Kim、Lianhong Xu
    DOI:10.1016/j.tetlet.2007.03.008
    日期:2007.4
    A facile construction of the 3,6-diamino-1,2,3,4-tetrahydropyridine-4-one class of compounds is described. Compound 2, a carbon analog at the N-3 position of TAN-1057A/B, was synthesized using this approach. (c) 2007 Elsevier Ltd. All rights reserved.
  • First enantioselective synthesis of the novel antiinfective TAN-1057A via its aminomethyl-substituted dihydropyrimidinone heterocycle
    作者:Vladimir N. Belov、Michael Brands、Siegfried Raddatz、Jochen Krüger、Sofia Nikolskaya、Viktor Sokolov、Armin de Meijere
    DOI:10.1016/j.tet.2004.06.034
    日期:2004.8
    Enantiomerically pure N-2-Z-N-2-MeAsnOH [(S)-14], prepared in 8 steps (23% overall yield) from asparaginic acid, was first subjected to a Hofmann degradation with PhI(OCOCF3)(2) yielding (S)-N-2-Z-N-2-methyl-2,3-diaminopropanoic acid [N-2-Z-N-2-Me-L-A(2)pr, (S)-15], and this in turn was protected to give N-2-Z-N-3-Boc-N-2-Me-L-A(2)pr [(S)-17]. Condensation of (S)-17 with HN=C(SMe)NHCONH2 followed by removal of the tert-butoxycarbonyl protecting group, cyclization and hydrogenolytic removal of the Z-group gave the heterocycle of TAN-1057A [(S)-1] with an e.e. of 87 in 36% yield [from (S)-14]. Coupling of (S)-1 with (S)-tris-Z-beta-homoarginine (20a) in the presence of O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) and iPr(2)NEt in N,N-dimethyl-acetamide followed by hydrogenolysis afforded the most active A-diastereomer of the natural antibiotic TAN-1057 in 52% yield (from (S)-1 and 20a). Similarly, starting from (S)-1, a single diastereomer of the potent, less toxic TAN-1057A analogue 22b with a beta-lysine side chain has been prepared. All described synthetic steps do not require column chromatography for purification of the products. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫